Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Dare Bioscience (DARE) over the last 10 years, with Q3 2025 value amounting to -$84506.0.

  • Dare Bioscience's Other Working Capital Changes rose 7338.51% to -$84506.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 5670.09%. This contributed to the annual value of -$3.6 million for FY2024, which is 49297.14% down from last year.
  • Per Dare Bioscience's latest filing, its Other Working Capital Changes stood at -$84506.0 for Q3 2025, which was up 7338.51% from $203760.0 recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Other Working Capital Changes ranged from a high of $4.3 million in Q1 2022 and a low of -$1.3 million during Q1 2024
  • In the last 5 years, Dare Bioscience's Other Working Capital Changes had a median value of -$84506.0 in 2025 and averaged $82874.9.
  • In the last 5 years, Dare Bioscience's Other Working Capital Changes soared by 207700.33% in 2022 and then tumbled by 90028.93% in 2024.
  • Dare Bioscience's Other Working Capital Changes (Quarter) stood at -$39513.0 in 2021, then plummeted by 455.54% to -$219510.0 in 2022, then skyrocketed by 138.43% to $84353.0 in 2023, then plummeted by 900.29% to -$675068.0 in 2024, then surged by 87.48% to -$84506.0 in 2025.
  • Its Other Working Capital Changes was -$84506.0 in Q3 2025, compared to $203760.0 in Q2 2025 and -$673510.0 in Q1 2025.